HomeNewsBusinessEconomyAfter Goldman Sachs and Nomura, economists warn of more cuts in FY22 GDP forecasts

After Goldman Sachs and Nomura, economists warn of more cuts in FY22 GDP forecasts

Economists of other agencies like SBI and ICRA say that the impact of rising COVID cases and more localized lockdowns will have a significant impact on their GDP forecasts.

April 15, 2021 / 15:20 IST
Story continues below Advertisement
Migrant workers going back home due to lockdowns. [Image: Shutterstock]
Migrant workers going back home due to lockdowns. [Image: Shutterstock]

The threat to gross domestic product (GDP) from the second pandemic surge looms large.

As India faces a massive rise in COVID-19 cases, and the possibility of more localized lockdowns becomes a reality leading to a possible drop in economic activity, analysts warn that GDP forecasts for 2021-22 could be revised downwards.

Story continues below Advertisement

So far, Goldman Sachs and Nomura have cut their GDP forecast for the fiscal year which began April 1.

Goldman Sachs has cut its forecast to a 10.5 per cent growth from 10.9 percent earlier, saying that a record number of pandemic cases and a host of key states announcing stricter lockdowns of late, have fuelled serious growth concerns, leaving investors worried about the risks to macro and earnings recovery.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show